SH-Alb inhibits phenotype remodeling of pro-fibrotic macrophage to attenuate liver fibrosis through SIRT3-SOD2 axis

MLA

Nijin Wu, et al. “SH-Alb Inhibits Phenotype Remodeling of pro-Fibrotic Macrophage to Attenuate Liver Fibrosis through SIRT3-SOD2 Axis.” Biomedicine & Pharmacotherapy, vol. 176, no. 116919-, July 2024. EBSCOhost, https://doi.org/10.1016/j.biopha.2024.116919.

APA

Nijin Wu, Shujun Ma, Han Ding, Huiling Cao, Tiantian Liu, Miaomiao Tian, Qiqi Liu, Hongjun Bian, Zhen Yu, Chenxi Liu, Le Wang, Yuemin Feng, Hao Wu, & Jianni Qi. (2024). SH-Alb inhibits phenotype remodeling of pro-fibrotic macrophage to attenuate liver fibrosis through SIRT3-SOD2 axis. Biomedicine & Pharmacotherapy, 176(116919-). https://doi.org/10.1016/j.biopha.2024.116919

Chicago

Nijin Wu, Shujun Ma, Han Ding, Huiling Cao, Tiantian Liu, Miaomiao Tian, Qiqi Liu, et al. 2024. “SH-Alb Inhibits Phenotype Remodeling of pro-Fibrotic Macrophage to Attenuate Liver Fibrosis through SIRT3-SOD2 Axis.” Biomedicine & Pharmacotherapy 176 (116919-). doi:10.1016/j.biopha.2024.116919.